Parecoxib Sodium, with CAS number 198470-85-8, is a pharmaceutical compound that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is a selective cyclooxygenase-2 (COX-2) inhibitor and is primarily used for its analgesic (pain-relieving) and anti-inflammatory properties.
Parecoxib Sodium is a sodium salt of parecoxib, which is a prodrug. It is a medication used for the management of acute postoperative pain and acute pain associated with certain medical conditions. Parecoxib Sodium is administered intravenously and is rapidly converted to its active form, valdecoxib, in the body.

Product: Parecoxib Sodium CAS 198470-85-8
Alternative Name: Parecoxib Sodium; Parecoxib; Parecoxib Sodium API; Parecoxib Sodium API;
Chemical Name: 4-(5-methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide sodium salt
Molecular formula: C19H18N2O4S·Na
Molecular mass: 392.409
CAS No.: 198470-85-8
EINECS Number: 813-689-5
MDL Number: MFCD04972608
Here are some of the benefits associated with the use of Parecoxib Sodium:
1. Effective Pain Relief: Parecoxib Sodium is primarily used for the management of acute pain, particularly postoperative pain. It can provide significant pain relief, allowing patients to recover more comfortably after surgical procedures or other medical interventions.
2. Anti-inflammatory Action: Parecoxib Sodium belongs to the class of selective cyclooxygenase-2 (COX-2) inhibitors, which means it specifically targets the COX-2 enzyme involved in inflammation. By inhibiting COX-2, it helps reduce inflammation and associated symptoms, such as swelling, redness, and heat.
3. Rapid Onset of Action: When administered intravenously, Parecoxib Sodium quickly converts to its active form, valdecoxib. This rapid conversion allows for a faster onset of action, providing prompt pain relief and anti-inflammatory effects.
4. Short-term Use: Parecoxib Sodium is typically used for short periods, primarily for acute pain management. This makes it suitable for addressing immediate pain needs, such as postoperative or post-procedural pain, rather than long-term chronic pain conditions.
5. Reduced Gastrointestinal Risks: Compared to non-selective NSAIDs, which inhibit both COX-1 and COX-2 enzymes, Parecoxib Sodium offers a potential advantage in terms of gastrointestinal safety. By selectively targeting COX-2, it may pose a lower risk of gastrointestinal side effects, such as stomach ulcers and bleeding.
6. Intravenous Administration: Parecoxib Sodium is administered intravenously, allowing for precise dosage control and rapid delivery of the medication. This route of administration ensures reliable absorption and distribution throughout the body.
1. Payment term
TT, LC
2. Delivery date
Negotiable
3. Market
Middle East / Africa / Asia / South America / Europe
4. Sample
Available
5. Executive standards
USP/EP
6. Qualification certificate
Registration "A" status of raw material
7. Packaging size specification
Inner package: single-layer polyethylene bag and aluminum foil bag.
Outer package: fiber drum.
Packaging size: 25 kg/drum.
Our Advantage
We have branch offices in Dubai and India
we have own reliable & Long-term cooperative & experienced factory
Variety products for selection from China and India
We can customize according to your requirements
We can do OEM & ODM
We can offer N-1 to API
Parecoxib Sodium CAS 198470-85-8 API FAQ
Q: What is parecoxib sodium?
Q: What conditions or diseases does parecoxib sodium treat?
Q: How does parecoxib sodium work?
Q: What are the possible side effects of parecoxib sodium?
Q: Who should not take parecoxib sodium?
Q: Is parecoxib sodium safe during pregnancy and breastfeeding?
Q: Can I drive or operate machinery while taking parecoxib sodium?
Hot Tags: parecoxib sodium cas 198470-85-8, China parecoxib sodium cas 198470-85-8 manufacturers, suppliers, factory, api to access human information, intermediate substrates, intermediate polymers, intermediate derivatives, api for human body metrics, api for human social media data







